MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Bio-Rad Laboratories Total Non Current Liabilities 2011-2026 | BIO
Annual Total Non Current Liabilities Bio-Rad Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.35 B | 1.14 B | 840 M | 792 M | 780 M | 709 M | 715 M | 956 M | 893 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.35 B | 709 M | 908 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 14.07 | 0.21 % | $ 2.11 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 6.86 | 3.63 % | $ 493 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 13.12 | -13.44 % | $ 355 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
1.61 M | $ 31.16 | -0.21 % | $ 1.43 B | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.49 | -2.18 % | $ 167 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.4 | -0.58 % | $ 118 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 24.27 | 2.1 % | $ 205 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 40.1 | 0.53 % | $ 5.98 K | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 74.86 | 1.87 % | $ 111 B | USA |
 |
InMode Ltd.
INMD
|
12.5 M | $ 14.01 | 0.32 % | $ 906 M | Israel |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 101.93 | 1.42 % | $ 1.29 B | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 46.53 | 1.2 % | $ 1.44 B | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
516 M | $ 70.52 | 0.33 % | $ 3.85 B |  Britain |
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
29.6 B | $ 96.9 | 0.25 % | $ 125 B | USA |
 |
MiMedx Group
MDXG
|
65.4 M | $ 5.07 | -4.06 % | $ 749 M | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 9.12 | -10.68 % | $ 260 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
6.91 M | $ 2.44 | -0.41 % | $ 143 M | Israel |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
53.7 M | $ 75.24 | -3.9 % | $ 2.12 B |  Costa-rica |
 |
Insulet Corporation
PODD
|
1.06 B | $ 251.19 | 1.24 % | $ 17.7 B | USA |
 |
Quanterix Corporation
QTRX
|
21.5 M | $ 6.11 | -2.86 % | $ 230 M | USA |
 |
FONAR Corporation
FONR
|
36.4 M | $ 18.55 | -0.19 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.9 | -1.36 % | $ 10.8 M | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 95.66 | -0.58 % | $ 12.9 B | USA |